MINNEAPOLIS, Aug. 7, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended June 30, 2024. The quarterly dividend will be payable August 30, 2024, to all common shareholders of record on August 19, 2024. Future cash dividends will be considered by the Board of Directors on a quarterly basis. Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bio ...

MINNEAPOLIS, July 31, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) is pleased to announce the launch of the Leo™ System. This next-generation Simple Western™ instrument offers higher throughput, flexibility, and efficiency over the current Jess™ and Abby™ Simple Western Systems. This stateof-the-art instrument enables simultaneous processing of up to 100 samples in a single 3-hour run, allowing scientists to process more samples in a day. Leo also provides 4-times the experimental size of Jess ...

MINNEAPOLIS, July 29, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced its participation in Spear Bio's $45 million Series A funding round. Spear Bio will use the proceeds from this funding round to further accelerate product development and scale its in-house manufacturing capacity. BioTechne joined Foresite Capital, and other investors, in this funding round. Founded in 2021 and headquartered in Woburn, Massachusetts, Spear Bio is an innovative leader in the development, and manu ...

Core Viewpoint - Oddity Tech Ltd. and certain executives are facing charges for failing to disclose material information during the Class Period, which is a violation of federal securities laws [1]. Group 1: Legal Proceedings - Investors have until September 17, 2024, to file lead plaintiff applications in a securities class action lawsuit against Oddity, covering purchases made between July 19, 2023, and May 20, 2024 [2]. - The lawsuit is currently pending in the United States District Court for the Eastern District of New York [2]. - The case is identified as Hoare v. Oddity Tech Ltd., et al., 24-cv-05037 [5]. Group 2: Allegations Against Oddity - NINGI Research reported multiple allegations against Oddity, claiming the company misled investors about critical aspects of its business [4]. - Allegations include that Oddity's AI is merely a questionnaire and that its reported "repeat purchase rates" are due to customers unknowingly entering non-cancelable plans [4]. - NINGI also found numerous undisclosed lawsuits against Oddity and its subsidiaries in the US and Israel, often related to unpaid bills and consumer protection law violations [4]. Group 3: Market Reaction - Following the news of the allegations, Oddity's share price dropped by $3.02, or 7.37%, closing at $37.97 per share on May 21, 2024 [7].

NEW ORLEANS, July 23, 2024 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until September 17, 2024 to file lead plaintiff applications in a securities class action lawsuit against ODDITY Tech Ltd. ("Oddity" or the "Company") (NasdaqGM: ODD), if they purchased the Company's securities between July 19, 2023 and May 20, 2024, inclusive (the "Class Period"). This action is pending in the United State ...

Click here to participate in the action. If you purchased or otherwise acquired Oddity Tech shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at investigations@bespc.com, telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you ...

These are just a few of the metrics contributing to GMAB's Value grade of B and TECH's Value grade of D. There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The proven Zacks Rank puts an emphasis on earnings estimates and estimate revisions, while our Style Scores work to identify stocks with specific traits. Value investors also tend to look at a n ...

Core Viewpoint - Genmab A/S Sponsored ADR (GMAB) is currently viewed as a better value opportunity compared to Techne (TECH) based on various valuation metrics and earnings outlook [1][6]. Valuation Metrics - GMAB has a P/B ratio of 3.57, while TECH has a higher P/B of 5.57, indicating GMAB is more undervalued relative to its book value [3]. - The forward P/E ratio for GMAB is 23.03, significantly lower than TECH's forward P/E of 34.71, suggesting GMAB is more attractively priced [5]. - GMAB's PEG ratio stands at 0.93, which is favorable compared to TECH's PEG ratio of 6.51, indicating better expected earnings growth relative to its price [5]. Earnings Outlook - GMAB holds a Zacks Rank of 2 (Buy), indicating a positive earnings outlook, while TECH has a Zacks Rank of 3 (Hold), suggesting a less favorable earnings forecast [4]. - The positive earnings estimate revisions for GMAB further support its superior position in terms of earnings outlook compared to TECH [4][6]. Value Grades - GMAB has received a Value grade of B, reflecting its strong valuation metrics, while TECH has a Value grade of D, indicating weaker valuation characteristics [9].

CETI's focus is to treat and repurpose a substantial amount of the water it receives from oil fields. Posttreatment, this water can be reused by oil companies, in agriculture, or even as drinking water where needed. Globally, agriculture consumes about 70% of freshwater resources, making CETI's water remediation capabilities particularly valuable to local communities and Industries. ABOUT CYBER ENVIRO-TECH, INC. CETI is an international eco-conscious, oil/sludge, water and soil remediation Company. Using bi ...

CETI's proprietary products and systems utilize environmentally friendly biologics which negate the need for chemical inputs and create a simpler process which reduces operational costs and initial capital outlay. In addition, CETI's water remediation approach has a much higher Standard Removal Proficiency by achieving 100% removal efficiency, far exceeding alternative approaches like ADS/DEP. These traditional processes only reach an approximate 43% removal, or 66% with more chemicals. "I find myself inund ...